Charles River Laboratories (CRL)
Profitability ratios
Return on sales
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit margin | 66.51% | 68.62% | 68.58% | 69.59% | 79.85% | 79.89% | 80.27% | 78.83% | 78.05% | 67.94% | 58.40% | 47.32% | 37.54% | 37.53% | 36.80% | 37.39% | 36.92% | 36.81% | 37.01% | 37.17% |
| Operating profit margin | 15.07% | 14.99% | 15.05% | 15.81% | 15.85% | 17.40% | 18.05% | 17.05% | 17.05% | 16.38% | 16.48% | 15.77% | 15.13% | 14.95% | 13.81% | 14.06% | 13.53% | 13.76% | 13.95% | 14.24% |
| Pretax margin | 14.05% | 14.15% | 14.44% | 15.06% | 15.02% | 14.10% | 14.51% | 14.36% | 13.67% | 14.49% | 15.66% | 15.51% | 15.60% | 13.77% | 11.75% | 10.92% | 11.64% | 10.82% | 11.26% | 12.14% |
| Net profit margin | 11.58% | 10.98% | 11.25% | 11.71% | 11.84% | 11.51% | 12.04% | 11.72% | 11.30% | 11.90% | 12.48% | 12.80% | 12.74% | 10.92% | 10.06% | 9.27% | 9.71% | 9.23% | 9.08% | 9.77% |
Charles River Laboratories has shown fluctuating trends in its profitability ratios over the past few quarters. The gross profit margin has been relatively stable, ranging between 66.51% and 80.27%. However, there was a significant drop to 58.40% in the June 2021 quarter before recovering.
The operating profit margin has also varied, with figures oscillating between 13.81% and 18.05%. The highest operating profit margin was recorded in the June 2022 quarter, while the lowest was in the December 2019 quarter.
Similarly, the pretax margin has shown fluctuations between 10.82% and 15.66%, with the highest figure noted in the June 2021 quarter. The net profit margin has ranged from 9.06% to 12.80%, experiencing some peaks and troughs throughout the periods analyzed.
Overall, Charles River Laboratories has demonstrated resilience in maintaining reasonable profitability margins, even though there have been fluctuations over the quarters. It would be valuable to monitor these ratios closely to assess the company's financial performance and efficiency in generating profits.
Return on investment
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | 7.53% | 8.52% | 8.33% | 8.70% | 8.56% | 8.94% | 8.83% | 8.69% | 8.40% | 7.74% | 7.78% | 7.96% | 7.88% | 7.91% | 7.11% | 7.22% | 7.48% | 7.53% | 7.27% | 8.49% |
| Return on assets (ROA) | 5.79% | 6.24% | 6.23% | 6.45% | 6.40% | 5.91% | 5.89% | 5.97% | 5.57% | 5.62% | 5.89% | 6.46% | 6.63% | 5.78% | 5.18% | 4.76% | 5.37% | 5.05% | 4.73% | 5.83% |
| Return on total capital | 19.80% | 22.68% | 22.67% | 23.24% | 22.71% | 21.73% | 21.74% | 21.88% | 21.57% | 23.84% | 25.66% | 25.45% | 25.18% | 24.13% | 21.77% | 21.65% | 22.20% | 21.17% | 23.11% | 24.80% |
| Return on equity (ROE) | 13.20% | 14.37% | 14.89% | 15.97% | 16.34% | 16.61% | 16.74% | 16.19% | 15.42% | 16.34% | 17.08% | 17.17% | 17.23% | 15.89% | 15.48% | 14.99% | 15.42% | 15.10% | 15.04% | 16.37% |
Charles River Laboratories has consistently shown strong profitability ratios over the past few quarters.
The operating return on assets (Operating ROA) has been relatively stable, ranging from 7.11% to 8.94%. This indicates that the company is efficiently generating operating profits from its assets.
The Return on Assets (ROA) has also been steady, with figures ranging from 4.76% to 6.63%. This ratio reflects the overall profitability of the company in relation to its total assets.
Return on total capital has shown a positive trend, ranging from 19.80% to 25.66%. This metric demonstrates how effectively the company is utilizing its capital to generate profits.
Return on equity (ROE) has also been consistently strong, varying between 13.20% and 17.23%. This ratio highlights the company's ability to generate returns for its equity holders.
Overall, Charles River Laboratories has demonstrated a solid profitability performance with stable and healthy ratios across the board.